NSE: SUPRIYA | BSE: 543434

Expensive Performer

Download real time

726.25 80.40 (12.45%)

High volume+gain today

NSE 21 Mar, 2025 3:31 PM (IST)

5,845.1

Market Cap

Above industry Median

1.6

Beta 1Year

Very High Volatility

Supriya Lifescience Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for SUPRIYA, BSE:543434 Supriya Lifescience Ltd.

Supriya Lifescience Ltd.

18 Aug 2022

726.25

12.45%

Improving capabilities towards sustainable growth.

Accumulate: Supriya Lifescience Ltd.

KRChoksey

During Q1FY23, Supriya Lifescience Ltd (SLL) reported Revenue of INR 1,037 Mn (+31.43% YoY / -43.98% QoQ).

Supriya Lifescience Ltd.'s price crossed above 100Day SMA today

Supriya Lifescience Ltd.

16 Dec 2021

726.25

12.45%

SUPRIYA LIFESCIENCES LTD.

IPO Note: Supriya Lifescience Ltd.

Hem Securities

Supriya Lifescience is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development. As of October 31, 2021, company have niche product offerings of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic,...

Supriya Lifescience Ltd.'s price crossed above 30Day SMA today

Supriya Lifescience Ltd.

16 Dec 2021

726.25

12.45%

Supriya Lifescience : IPO

IPO Note: Supriya Lifescience Ltd.

ICICI Securities Limited

Supriya has been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-50% and 60-65%, respectively, of the API exports from India, between FY17 and FY21. SLL is among the largest exporters of Salbutamol Sulphate in India contributing to...

Supriya Lifescience Ltd.'s price crossed above 100Day SMA today

Supriya Lifescience Ltd.

15 Dec 2021

726.25

12.45%

Supriya Lifescience Ltd

IPO Subscribe: Supriya Lifescience Ltd.

Angel Broking

Supriya Lifescience Limited was incorporated in March 2008 by Satish Waman Wagh. Company is one of the key Indian manufacturers and suppliers of active pharmaceutical ingredients (APIs). Supriya Lifescience Limited focus on research and development along with this company focus is on diverse therapeutic areas and niche products. Company has niche product offerings of 38

Supriya Lifescience Ltd. is trading above all available SMAs

Supriya Lifescience Ltd.

15 Dec 2021

726.25

12.45%

SUPRIYA LIFESCIENCE LTD.

IPO Note: Supriya Lifescience Ltd.

Ventura

IPO NOTE

Supriya Lifescience Ltd. is trading above all available SMAs

Supriya Lifescience Ltd.

15 Dec 2021

726.25

12.45%

Supriya Lifescience Ltd. IPO Note

IPO Note: Supriya Lifescience Ltd.

Ashika Research

Public issue of 2,55,47,445 Equity shares of Face value Total Public 2 each, (Comprising of fresh issue of 72,99,270 Equity Shares* (Rs. 200 cr.) and Offer for Sale of 1,82,48,175 Equity Shares* (Rs. 500 cr.) by Selling Shareholder)....

Supriya Lifescience Ltd.'s price crossed above 100Day SMA today

No results found

VOTE: Is Supriya Lifescience Ltd. worth buying?

95 Votes:

Buy 85.26%

Sell 7.37%

Hold 7.37%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf